A price slash for Coach (COH) may have investors thinking twice before picking up the handbag maker stock. Credit Suisse (CS) lowered its price target for Coach to $30 per share from $39 due to future sales. The firm is keeping its Neutral rating for the stock. But a brighter outlook for a glaucoma drug maker, Aerie Pharmaceuticals (AERI). Canaccord initiated coverage of the drugmaker with a buy rating and a price target set at $40 per share. And Jefferies is raising its price target for Toyota Motors (TM) to $139.80 per share. The firm is also reiterating its BUY rating for the stock. TheStreet's Susannah Lee has the details in today's Analysts' Actions from Wall Street.